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Abstract
Mathematical modeling has proven to be an essential tool for the development of
control strategies and in distinguishing driving factors in disease dynamics. A key
determinant of a given model’s potential to aid in such measures is the availability
of data to parameterize the model. For developing countries in particular, data are
often sparse and difficult to collect. It is therefore important to understand the
types of data that are necessary for a modeling project to be successful. In this
thesis I analyze the value of particular types of data for a set of infections. The first
project analyzes the importance of considering age-specific mixing patterns in vaccine
preventable infections in which disease severity varies with age. The second project
uses a simulated data set to explore the plausibility of recovering the parameters of
an epidemiological model from a time series data set of dengue haemorrhagic fever
reports.
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1Introduction
Mathematical models have proven to be useful tools for the development of infectious
disease control strategies and for teasing apart the important underlying factors that
drive disease dynamics. Even very simple models can make surprisingly accurate
predictions. For example, an incredibly simple rubella model published by Knox
in 1985 (Knox, 1985) did a fairly accurate job of predicting what would happen
when Greece implemented a low coverage Rubella vaccination policy and saw a large
outbreak of Congenital Rubella Syndrome (CRS) in the early 1990s (Panagiotopoulos
et al., 1999). This model related the proportion of infants who acquire CRS to the
vaccination rate as a simple exponential function of the force of infection. While
simple models such as this can give important qualitative insights there is also a
need for more quantitative results. For the rubella example, simple models can
tell us that intermediate vaccination values can lead to bad outcomes, but a policy
maker needs to know whether vaccinating a particular proportion of a population
will increase or decrease the occurrence of CRS in the population and whether this
changes from one population to another. As one moves from simple models that
make mostly qualitative predictions to models can potentially make the quantitative
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predictions needed to address current public health problems, model parametrization
becomes both more important and more difficult. The available data often limit the
types of models that can be accurately fit.
Much of the need for mathematical modeling of infectious diseases is currently
occurring in developing countries where data are often noisy and sparse. Two of the
most important questions that must be addressed when conducting modeling in these
situations are “What data should I collect in the future?” and “What can be done
with the data that I have?” For this thesis, I present two projects, each addressing
one of these questions. The first project addresses the first question in the context of
vaccination policies for permanently immunizing diseases by using an age-structured
SIR1 model to illustrate the importance of collecting data on age structured mixing
patterns in developing countries. The second project addresses the second question
by demonstrating the potential for fitting simple dengue models to relatively short
time series, similar to a set of time series that are currently available for the different
provinces of Thailand.
1 SIR models group individuals into susceptible, infected and recovered compartments. Depend-
ing on the complexity of the model, there can be multiple subgroups within each of the three
compartments.
2
2The impact of age-assortative mixing on the value
of vaccination policies
2.1 Introduction
Vaccination policies aim to reduce the burden of infectious diseases on populations
through the immunization of susceptible individuals. These policies reduce incidence
through the direct effect of preventing infection and the indirect effect of establishing
herd immunity. Herd immunity is well known to facilitate disease elimination and, in
cases where elimination is not possible, to reduce the force of infection and increase
the average age of infection (Anderson and May, 1991, 1990). Infection severity
for many diseases depends at least partly on the age of the host; well-orchestrated
vaccination policies therefore take into account their dual effect on disease incidence
reduction and the age distribution of cases. Policies that fail to do so can have
unanticipated, counterproductive consequences. For example, a low coverage rubella
vaccination policy in Greece may have led to an increase in the number of congenital
rubella syndrome cases by shifting the average age of infection to childbearing years
(Panagiotopoulos et al., 1999).
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An important factor that is known to affect disease dynamics is the pattern of
social mixing in a population. These mixing patterns arise from many different
aspects of societal structure including school attendance, workplace interactions and
family structure. Some generalities in these mixing patterns are well established
empirically. For example, people tend to preferentially interact with others of similar
age (Mossong et al., 2008; Horby et al., 2011) and mixing rates between children
and parents are invariantly high (Mossong et al., 2008) (Figure 2.1 A). However,
appreciable country- and region-specific differences are also apparent. For example,
while the POLYMOD study (Mossong et al., 2008) indicates that mixing patterns
are remarkably similar across European countries, an analogous study in Vietnam
found lower tendencies for age-assortative mixing (Horby et al., 2011) (Figure 2.1 B).
Similar to the types of epidemiological models used to anticipate the age distribution
consequences of vaccination policies, models incorporating age-structured mixing
patterns have been instrumental in understanding and predicting patterns of disease
incidence and spread. For example, age-structured interactions have been invoked
to explain long-term changes in pertussis prevalence (Rohani et al., 2010). Age-
structured mixing patterns have also been used to evaluate the probability that a
newly emerging virus will spread through a naive host population (Nishiura et al.,
2011), and in the case of establishment, to evaluate the optimal allocation of vaccines
(Shim et al., 2011; Medlock and Galvani, 2009).
In this chapter, I consider how vaccination policies, in the context of age-assortative
mixing patterns, differentially affect the impact of disease incidence in a population.
Specifically, following previous approaches that couple economic models with epi-
demiological models (e.g. (Althouse et al., 2010)), I assess the direct and indirect
effects of a vaccination policy on a typical individual in a population under a range
of different mixing patterns. While the epidemiological model is used to anticipate
incidence levels and age distribution patterns under a proposed vaccination policy
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and under a given mixing pattern, the economic model combines these predictions
with information on age-dependent disease severity costs to quantify the direct and
indirect economic consequences of the vaccination policy. I combine these two effects
to assess the value of a vaccination policy.
2.2 Methods
The Epidemiological Model
I consider a dynamic epidemiological model with individuals classified as suscepti-
ble (S), infected (I), or recovered and immune to reinfection (R) that includes age
structure and assumes permanent immunity following either a primary infection or
vaccination. The epidemiological model is mathematically formulated by the follow-
ing set of partial differential equations:
BSpa, tq
Bt `
BSpa, tq
Ba “ ´λpa, tqSpa, tq
BIpa, tq
Bt `
BIpa, tq
Ba “ λpa, tqSpa, tq ´ γIpa, tq
BRpa, tq
Bt `
BRpa, tq
Ba “ γIpa, tq
(2.1)
with boundary conditions: Sp0, tq “ p1-ρqµN , Ip0, tq “ 0, and Rp0, tq “ ρµN .
The variables Spa, tq, Ipa, tq, and Rpa, tq are the number of susceptible, infected and
recovered individuals of age a at time t, respectively. The parameters of the model
are the infant vaccination rate ρ, the recovery rate γ, and the birth rate µ. I as-
sume a constant population size, N , with a life span of 75 years, such that all births
into age class 0 are matched by deaths of individuals at the age of 75. λpa, tq is
the age-specific force of infection, described in greater detail below. I numerically
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approximate the dynamics using the escalator boxcar train method (De Roos et al.,
1992). This approach divides the population into discrete age bins of width ∆a, such
that the dynamics are modelled as a system of ordinary differential equations instead
of the partial differential equations shown above. Aging is modelled by shifting in-
dividuals from the ith age bin to the pi ` 1qth age bin every ∆a time units. Here I
use an age bin width (∆a) of three months.
Modelling the age-specific force of infection, λpa, tq, requires an assumption on
the mixing patterns in the population. Because the level of age-assortative mixing
has been shown to be a useful metric for comparing mixing patterns across different
populations (Farrington et al., 2009; Nold, 1980; Newman, 2003; Iozzi et al., 2010),
I implement mixing using a variation of the preferred mixing matrix (Jacquez et al.,
1988). For simplicity I therefore assume that all individuals have the same number of
contacts, m, per unit time. I partition the population into age groups and define the
degree of assortative mixing as the percent of an individual’s contacts that are with
others in the same age-group. I use a parameter θ P r0, 1s to control this percentage
and assume that the remaining contacts are uniformly distributed between the other
age groups. Mathematically, this contact rate matrix C is given by:
Cri, js “
"
θm if i “ j
p1´θqm
η´1 if i ‰ j
(2.2)
where i, j P t1...ηu and η is the number of age groups. Figures 2.1(C-E) show con-
tact matrices for the values of θ used in our simulations. In transforming the contact
matrix, C into a transmission matrix M, I use an age-independent parameter φ to
model the probability that a contact between a susceptible and an infected individual
leads to a new infection, that is M “ φC. This is a common assumption in models
using contact rate matrices (Horby et al., 2011; Rohani et al., 2010; Wallinga et al.,
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2006) and has been demonstrated (at least in the case of pertussis) to be consistent
with empirical data (Rohani et al., 2010). With this formulation of the model the
basic reproduction number, R0, is approximately
mφ
γ
, which is independent of the
degree of assortative mixing, θ. This allows R0 to be calibrated for a specific disease
using only φ, γ and m. In this formulation, the force of infection experienced by a
susceptible individual of age a at time t is given by:
λpa, tq “ Σηj“1Mkj IjptqNjptq (2.3)
where k is the index of the age group to which the individual of age a belongs, Ijptq
is the number of infected individuals in age group j at time t, and Njptq is the total
number of individuals in age group j at time t.
The Economic Model
I now specify an economic model to assess the consequences of different levels of
age-assortative mixing on the value of a vaccination policy. To begin, I can evaluate
the expected cost of infection over an unvaccinated individual’s lifetime using the
equation:
Kpθ, ρq “
ż T
0
kpaqfpa | θ, ρqda (2.4)
where the function fpa|θ, ρq specifies the probability that an individual becomes
infected at age a, given a particular level of assortative mixing (θ) and vaccination
rate pρq, and T is the life span of an individual. The function kpaq provides the
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expected cost of infection at age a, which includes costs associated with hospital
care, lost productivity and permanent disability (Takahashi et al., 2011; Al-Awaidy
et al., 2006). I use the catalytic model (Muench, 1991) to write fpa|θ, ρq as a function
of the equilibrium age-specific force of infection for a particular level of assortative
mixing and vaccination coverage, λpa | θ, ρq:
fpa|θ, ρq “ λpa | θ, ρqe´
şa
0 λpx|θ,ρqdx (2.5)
This expected lifetime cost of infection can then be used to calculate the expected
value of the proposed vaccination policy to a typical individual in the population.
The expected cost of the disease with no vaccination policy is Kpθ, 0q. Under a vac-
cination policy with coverage level ρ, a vaccinated individual has an expected cost
of zero. The effect on this individual, which I call the direct effect, is the difference
between his expected cost under this policy and his expected cost under a no vacci-
nation policy. Under this same policy, the expected lifetime cost for an unvaccinated
individual is Kpθ, ρq. The effect of the policy on this individual, which I call the
indirect effect of the policy, is again the difference between the expected cost under a
no vaccination policy and the expected cost under the considered policy. Combining
these two effects, the expected value of a vaccination policy on a typical individual
is given by:
V pθ, ρq “ ρKpθ, 0q
direct effect
` p1-ρqpKpθ, 0q-Kpθ, ρqq
indirect effect
(2.6)
where the vaccination rate ρ is used to weight the direct and indirect effects of
vaccination. I use this framework to assess the value of a vaccination policy under
different age-assortative mixing patterns and under four distinct disease cost curves.
I first analyse the base case of age-independent costs. The remaining cost curves
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assume that severity peaks in either young, intermediate or elderly age groups.
2.3 Results
Effects of vaccination and age-assortative mixing on the age distribution of infection
Increases in population vaccination rates are well known to decrease the probability
that an unvaccinated individual becomes infected during his lifetime. Consistent
with this expectation, simulations of the dynamic epidemiological model described
above show lower lifetime infection probabilities at higher vaccination rates and also
indicate that these lifetime infection probabilities are independent of the degree of
age-assortative mixing (Figure 2.2 A), depending solely on the value of the basic
reproduction number, R0.
Increases in vaccination rates are also known to shift the average age of infection
(hereafter, AAOI) to older age groups (Anderson and May, 1991; Panagiotopoulos
et al., 1999; Keeling and Rohani, 2008). Again, consistent with this expectation, our
simulation results show increases in the AAOI with increases in vaccination rates
(Figure 2.2 B), regardless of the degree of assortative mixing. Interestingly, for any
given level of vaccination, these simulations also show that the AAOI is lower at
higher levels of age-assortative mixing (Figure 2.2 B). This is because, for diseases
with permanent immunity, young age groups have the highest proportion of infected
individuals. Higher levels of assortative mixing therefore result in higher forces of
infection for young individuals by increasing the proportion of a young person’s
contacts that are with infected individuals. This in turn lowers the AAOI.
Effects of vaccination and age-assortative mixing on the expected lifetime cost of
infection
The expected cost of disease over an unvaccinated individual’s lifetime (equation 2.4)
can now be calculated by incorporating the simulation results of the epidemiological
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model. I first consider the simplest case: when the cost of infection is independent
of an individual’s age (Figure 2.3 A). In this case, the expected cost reduces to
the product of the age-independent cost of infection, k, and the probability that
an individual becomes infected over his lifespan. The latter I have shown always
decreases with increases in vaccination rates and is independent of the level of age-
assortative mixing (Figure 2.2 A). When costs of infection are independent of age,
the extent of age-assortative mixing therefore does not influence the expected cost of
disease over an unvaccinated individual’s life (Figure 2.4 A) and higher vaccination
rates always act to decrease the expected cost. This latter result is consistent with
vaccination yielding a positive externality, in which unvaccinated individuals benefit
from the herd immunity generated by vaccinated individuals.
I now consider a cost curve for which infections at a younger age incur a greater
cost (Figure 2.3 B). Under this cost curve, the expected lifetime cost to an unvac-
cinated individual always decreases with increases in vaccination rates (Figure 2.4
B). This is because an increase in vaccination rate decreases the lifetime infection
probability of an unvaccinated individual as well as decreases the probability that
an unvaccinated individual who does become infected does so at a young age. These
simulations also show that the expected lifetime cost is higher at higher levels of
assortative mixing, for any given vaccination rate (Figure 2.4 B). This is because
the AAOI is lower at higher levels of age-assortative mixing (Figure 2.2 B).
When infections at an older age incur a greater cost (Figure 2.3 C), the expected
lifetime cost to an unvaccinated individual increases with an increase in the vaccina-
tion rate until close to the disease eradication threshold of 1- 1
R0
, at which point the
expected lifetime cost then decreases. This pattern arises from vaccination affecting
the expected cost in two ways. First, vaccination decreases the lifetime probability
of infection (Figure 2.2 A), which lowers the expected cost. Second, it increases the
average age of infection if an unvaccinated individual does become infected (Figure
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2.2 B), which increases the expected cost. Under our parameterization, the lifetime
probability of infection changes very little for low to intermediate vaccination rates
(Figure 2.2 A). In contrast, there is a relatively large change in the AAOI over
this same range of vaccination rates (Figure 2.2 B). This leads to an increasing ex-
pected cost over this range of vaccination rates. As the vaccination level approaches
the eradication threshold, however, there is a sharp drop in the lifetime probabil-
ity of infection (Figure 2.2 A), which leads to a decreased expected cost at higher
vaccination levels. Figure 2.4 C also shows that, for a given vaccination rate, the
expected lifetime cost of infection is lower at higher levels of assortative mixing. This
is because higher levels of age-assortative mixing result in lower AAOI (Figure 2.2
B).
The fourth class of diseases I consider are diseases that incur the highest cost of
infection at intermediate ages (Figure 2.3 D). Examples include rubella virus, which
can be passed from mother to fetus during pregnancy and cause congenital rubella
syndrome (CRS) in infants(Anderson and May, 1991), and mumps, which can lead
to infertility if adolescent boys become infected(Anderson et al., 1987). Figure 2.4
D shows the expected lifetime cost of infection for an unvaccinated individual under
this cost curve. In this case, intermediate values of vaccination again lead to the
highest expected cost of infection, a pattern that has been remarked upon previously
in the CRS literature (Knox, 1985; Panagiotopoulos et al., 1999; Morice et al., 2003).
Under our parameterization, the expected lifetime cost is also lower at higher levels
of assortative mixing. As before, this is because a higher level of assortative mixing
leads to younger AAOI and fewer infections during intermediate ages (Figures 2.2
B and 2.3 D).
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Effects of age-assortative mixing on the economic value of a vaccination policy
I now consider how a vaccination policy differentially affects vaccinated and unvac-
cinated individuals and how this impacts the overall value of a vaccination policy
for a typical individual (equation 2.6). Figure 2.5 A shows the economic value of
a vaccination policy for vaccinated and unvaccinated individuals, independently, in
the case of the age-independent cost curve shown in Figure 2.3 A. The direct value
of the vaccination policy, as defined in equation equation 2.6, is always independent
of vaccination level. Under this cost curve, the direct value of the policy is also
not sensitive to the level of age-assortative mixing (Figure 2.5 A). The indirect
value of the vaccination policy, defined in equation 2.6, increases with vaccination
level, showing the benefits of herd immunity to unvaccinated individuals. Because
the expected lifetime disease cost to an unvaccinated individual is in this case not
sensitive to the level of age-assortative mixing (Figure 2.4 A), the indirect value of
vaccination is also insensitive to θ. Figure 2.6 A combines the direct and indirect
values of vaccination, showing that the economic value of a vaccination policy for a
typical individual increases with vaccination level in the case of the age-independent
cost curve, and that the value is not sensitive to the level of age-assortative mixing.
For infections with higher severity at young ages (Figure 2.3 B), the direct value
of vaccination again is not affected by vaccination levels. However, the direct value
of vaccination is observed to be higher at higher levels of assortative mixing (Figure
2.5 B). This increase occurs because a higher level of assortative mixing shifts the
age distribution of infection to younger ages (Figure 2.2 B), which makes protection
against infection more valuable. The indirect value of vaccination also increases with
vaccination levels. For a fixed vaccination level, the value of vaccination is higher at
higher vaccination levels. Figure 2.6 B shows the overall expected value of vaccina-
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tion for the young cost curve. In this case the value also increases with vaccination
level. At any given vaccination level, the expected value of vaccination is higher at
higher levels of assortative mixing because higher levels of assortative mixing result
in younger, more severe infections.
The cost curve with highest severity in the elderly is the first curve I analyse to
show the potential for negative effects of a vaccination. Figure 2.5 C shows that
vaccination can have a small direct value on vaccinated individuals relative to the
negative indirect effect on unvaccinated individuals. In the absence of vaccination,
there is a very low probability that an elderly individual is susceptible; vaccina-
tion therefore only has a significant direct effect on the small number of individuals
who would have experienced infection at this age. At any given vaccination level,
higher levels of assortative mixing lower the direct value of vaccination. The indi-
rect value of vaccination, always negative in this case, is of a smaller magnitude at
higher levels of assortative mixing (Figure 2.5 C). These two patterns can be under-
stood considering the relationship between assortative mixing and AAOI at a fixed
vaccination level (Figure 2.2 B). A higher level of assortative mixing has a lower
AAOI, resulting in a lower average severity of infection. In the case of the elderly
cost curve, the direct value of vaccination is therefore lower at higher levels of as-
sortative mixing. The negative indirect value of vaccination is smaller in magnitude
because an unvaccinated individual on average becomes infected at a younger age
when assortative mixing is high, which leads to a less severe infection. Figure 2.6
C shows the expected value of vaccination for a typical individual under the elderly
cost curve. In this case the expected value is negative until the vaccination level
approaches the eradication threshold. This is because there is almost no direct value
of vaccination but there is a highly negative indirect effect of vaccination. For low
to intermediate vaccination levels, the expected value is less negative with higher
levels of assortative mixing because the negative indirect effect dominates over the
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direct effect. As the vaccination level approaches the eradication threshold however,
the direct effect of vaccination, which is higher at lower levels of assortative mixing,
begins to dominate and there is a switch in the order of the curves in Figure 2.6
C. These results suggest that a vaccination policy for diseases that have a strong
negative impact on the elderly and minimal effect on other age groups will have to
attain a coverage level very close to the eradication threshold before the direct pos-
itive effect on vaccinated individuals is able to counterbalance the negative indirect
effect on unvaccinated individuals. These results further suggest that even if cov-
erage does approach the eradication threshold the value of the policy will be minimal.
In the case where infection at intermediate ages has the highest severity (Figure
2.5 D), the direct value of a vaccination policy to a vaccinated individual is higher
at lower levels of assortative mixing. This is because the expected lifetime cost of
disease in the absence of a vaccination policy is higher at lower levels of assortative
mixing (see ρ “ 0 in Figure 2.4 D). At low vaccination values, the magnitude of the
negative indirect value of vaccination is smaller at higher levels of assortative mixing
because higher levels of assortative mixing drive the AAOI lower, away from the peak
of the cost curve. At higher vaccination levels, however, the relationship is reversed.
This is because at high vaccination levels, higher levels of assortative mixing shift
the AAOI lower, this time towards the peak of the cost curve (Figure 2.3 D). In this
case, the overall expected value of vaccination is negative for low vaccination values
and then passes a threshold vaccination rate after which a typical individual benefits
from the vaccination policy (Figure 2.6 D). This threshold depends on the degree of
assorative mixing, with higher vaccination rates needed to pass the threshold value
at higher levels of assortative mixing.
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2.4 Discussion
Using a simple age-structured epidemiological model I have investigated the role
of assortative mixing in modulating the age-profile of infections under an infant
vaccination policy. I have shown that high levels of assortative mixing result in a
younger AAOI. I then use an economic model to show that this difference in the
age-distribution of infection can have important consequences for the value of vacci-
nation policies.
For diseases like measles, which have highest severity in the very young, a vac-
cination strategy will always be more valuable in populations having higher levels
of assortative mixing (Figure 2.6 B) because in the absence of vaccination, these
populations will tend to have younger, more severe infections (Figure 2.2 B).
For diseases that have highest severity for intermediate-aged infections, simula-
tion results indicate that vaccination policies will need to surpass a threshold cov-
erage level before they have a net positive effect on the population. While this is
well established in the literature (Knox, 1985; Panagiotopoulos et al., 1999), the
current analysis indicates that this threshold value depends on the level of assorta-
tive mixing in the population. This is especially relevant for developing countries
which are considering rubella elimination campaigns and others where vaccines have
been introduced onto the private market (Robertson et al., 1997) because there is
a concern that this introduction may lead to an increase in the number of cases of
congenital rubella syndrome, similar to what was seen in Greece in the early 1990s
(Panagiotopoulos et al., 1999). A recent survey study in Vietnam indicated that
mixing patterns in developing countries may have a significantly lower level of as-
sortative mixing than those in developed populations. If this is the case, the results
presented here indicate that a developing country may not need to attain as high a
vaccination level in order to see positive benefits from a rubella vaccination policy.
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In the model presented, a high premium was put on simplicity. Other impor-
tant factors that were not considered here include the effects of mixing between
parents and children, age-specific differences in the total number of daily contacts,
and maternally derived immunity. The availability of self-reported contact data has
in many ways solved the past problem of making ad-hoc assumptions on assumed
contact patterns in disease models for developed countries. However, with a notable
exception in Vietnam (Horby et al., 2011), these data do not exist for developing
countries. There is therefore still a need for assumptions to be made on mixing pat-
terns when modelling the impact of control strategies in developing countries. The
results presented here highlight the need to check the robustness of modelling results
to uncertainties in mixing patterns, particularly when analysing the expected impact
of a control strategy.
The framework developed here can easily be extended to incorporate additional
complexities or to look at different disease systems and control methods. For ex-
ample, this framework could easily be modified to explore the possible effects of
the introduction of the MMR vaccine in a developing country. The MMR vaccine
has been introduced in the private market in many developing countries (Robertson
et al., 1997), where it could lead to an increase in the number of cases of congenital
rubella syndrome and male infertility caused by mumps if high coverage levels are
not quickly attained. Preventing this increase in disease severity while also taking
advantage of the efficiency of combined vaccines will require a model that is able to
integrate all three diseases into one framework that takes into account the age-specific
severity profiles of each disease.
16
Figure 2.1: Age-assortative mixing patterns. (A) An estimated contact rate
matrix, reproduced from [4]. The matrix was estimated using survey data from the
European POLYMOD study and smoothed as described in (Mossong et al., 2008).
White indicates high contact rates, green intermediate contact rates, and blue low
contact rates, relative to the country-specific contact intensity. (B) Estimates of the
percent of within age-group contacts for Finland (Mossong et al., 2008) and Vietnam
(Horby et al., 2011). Data were kindly provided by the authors of these papers. (C-
E) Contact rate matrices used in the epidemiological model simulations. Individuals
were binned into five year age groups. The level of assortative mixing, θ, is defined as
the proportion of an individual’s contacts that are with other individuals in his/her
age group. With age groups of five years and a host lifespan of 75 years, I consider
values of θ representing homogenous mixing (θ “ 1
15
, subplot C), an intermediate
level of assortative mixing (θ “ 3
15
, subplot D) and a high level of assortative mixing
(θ “ 5
15
, subplot E).
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Figure 2.2: Simulation results from the epidemiological model. (A) The
lifetime probability of infection as a fraction of vaccination level, ρ. (B) The average
age of infection(AAOI) as a fraction of vaccination level,ρ under a range of vaccina-
tion rates for three different levels of assortative mixing (θ “ 1
15
, 3
15
, and 5
15
). The
epidemiological model was parameterized with m “ 13 contacts per day, infectious
period 1
γ
= 14 days, and infectivity parameter φ “ 1
30
, yielding a value of R0 of
approximately 6.
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Figure 2.3: Disease cost curves. (A) An age-independent disease cost curve,
with cost kpaq set to 50. (B) A disease cost curve with higher infection costs in the
young. The curve kpaq is proportional to expp-1
8
aq (C) A disease cost curve with
higher infection costs in the elderly. The curve kpaq is proportional to expp-1
8
p75-aqq
(D) A disease cost curve peaking at intermediate ages. The cost curve is proportional
to a smoothed fecundity curve for Vietnam and therefore can represent this country’s
rubella cost curve. All curves are scaled to have a mean cost of fifty across ages.
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Figure 2.4: Expected lifetime cost of infection to an unvaccinated indi-
vidual, Kpθ, ρq. (A) The expected lifetime cost of infection for the age-independent
cost curve (Figure 3A). (B) The expected lifetime cost of infection for the cost curve
with highest severity in the young (Figure 3B). (C) The expected lifetime cost of
infection for the cost curve with highest severity in the elderly (Figure 3C). (D)
The expected lifetime cost of infection for the infections with highest severity at
intermediate ages (Figure 3D).
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Figure 2.5: The direct and indirect value of vaccination. Solid lines show
the direct value and dashed lines show the indirect value when disease severity is
(A) independent of age, (B) highest in the young, (C) highest in the elderly and (D)
highest for intermediate ages for different levels of assortative mixing. In all cases the
direct value converges to the indirect value as the vaccination level approaches the
eradication threshold. Grey lines in (C,D) illustrate where the value of vaccination
is zero.
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Figure 2.6: The expected value of vaccination for a typical individual
in the population For different levels of assortative mixing, subplots show the
expected value of vaccination when disease severity is (A) independant of age, (B)
highest in the young, (C) highest in the elderly and (D) highest for intermediate
ages. Grey lines indicate where the value of vaccination is 0.
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3Bayesian Parameter Inference of a Four Serotype
Dengue Model Using Monthly Dengue Hemorrhagic
Fever Case Report Data
3.1 Introduction
Dengue is a vector-borne virus that affects 390 million people every year (Bhatt et al.,
2013). Dengue virus is categorized into four distinct serotypes. Infection with any
one serotype is thought to grant the infected person permanent immunity to that
serotype, but may lead to enhanced severity for infection with one of the other three
serotypes. This enhanced severity is thought to arise through a process known as an-
tibody dependant enhancement (ADE) in which heterologous antibody present from
the primary infection binds to the virus but cannot neutralize it. This antibody-
virus complex then binds to fcγ receptors present on monocytes. These monocytes,
which are not easily infected in the absence of antibody, are then infected by the
virus which leads to increased viral replication and more severe manifestations of
the disease (Whitehead et al., 2007). However, the majority of infections are either
asymptomatic or mild (Burke et al., 1988) (Endy et al., 2002).
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There is a vast literature on dengue modelling and which factors of this com-
plex infection are important to include for various modeling aims (Johansson et al.,
2011). Some models include the vector population explicitly (Focks et al., 1995)
(Keeling and Rohani, 2008) while others do not (Nagao and Koelle, 2008) (Wearing
and Rohani, 2006) (Adams and Boots, 2006) (Coutinho et al., 2006). Other factors
that are sometimes included in dengue models include seasonality (Wearing and Ro-
hani, 2006), enhancement of secondary infections (Adams and Boots, 2006) (Billings
et al., 2007) (Medlock and Galvani, 2009) and temporary cross protection between
serotypes (Wearing and Rohani, 2006) (Nagao and Koelle, 2008). While many of
these models reproduce dynamics that are qualitatively similar to those observed
empirically, little has been done in the area of formal model fitting and compari-
son. This is an important problem both for ecologists who wish to quantitatively
compare different hypothesis about factors driving disease dynamics and for policy
makers who need to choose and fit models for making predictions on the possible
impacts of proposed control strategies.
Fitting mechanistic epidemiological models to data is a difficult problem. Many
parameters cannot be directly measured and must be inferred from their effects on
the dynamics of case report data. Even some of the simplest disease models are
highly non-linear and case report data are often very noisy and only available for
a limited number of years. These problems are particularly important for dengue
models. The four serotypes of dengue often lead to high dimensional models and
stiff systems of equations1. This is a problem because for non-linear models one of
the best (and only) inference techniques available involves simulating hundreds of
thousands of years worth of data from the model each time a likelihood value needs
to be estimated (Doucet et al., 2001) (Andrieu and Doucet, 2010) (Ionides et al.,
1 Here the term ”stiff” is used to mean that the time step over which it is safe to assume that the
rates of each type of event in the system remains constant is small.
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2006). The high dimensionality means that each step is expensive and the stiffness
means that small step sizes are needed during simulation. Depending on whether a
frequentist (Ionides et al., 2006) or Bayesian approach (Andrieu and Doucet, 2010) is
taken, hundreds of thousands of likelihood evaluations may be needed for each model
that is being fit and compared. In addition to these difficulties with the underlying
model, case report data for dengue are often only available for dengue hemorrhagic
fever cases, without serotye classification. This makes inference difficult because the
data that are available to fit the model is mostly comprised of a small fraction of sec-
ondary infections and it is not clear whether the unknown parameters have enough of
an effect on these dynamics to make inference possible. The only study to date using
these techniques to look at parameter inferrability in the context of multi pathogen
models looked at fitting a two serotype model to a forty year long mock time series
data set where the serotype of each case was known (Shrestha et al., 2011). The
study also assumed that the epidemiological parameters of the model were known
and fit only a subset of the unknown parameters. This project looks at the feasibility
of inferring all of the unknown parameters from a simple four serotype dengue model
on a mock time series data set. This mock data set is comprised of monthly reported
DHF cases over a twenty year time span which is similar to what is seen in real
data sets. This project frames the inference problem in a Bayesian context and uses
particle Markov Chain Monte Carlo for inference.
3.2 Methods
3.2.1 State space model
Fitting mechanistic disease models to time series data is generally done in the con-
text of state space models which are comprised of an observation model and an
underlying process model that describes the true underlying state of the population.
The process model used for this project is a four sertoype SIR model. This process
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model is coupled to a time series of mock monthly DHF incidence using a binomial
observation process model described below.
For the SIR model, individuals are grouped by how many infections they have
had. It is assumed that each serotype has equal prevalence in the population, that is,
each serotype makes up 1
4
of the total number of infected individuals. Those in group
Si have recovered from i strains and are susceptible to 4-i strains. The force of infec-
tion is 4-i
4
times the full force of infection, βptqS0Itot. Individuals in category Ii are
experiencing their ith infection. The model also keeps track of the cumulative number
of secondary infections which is needed for the observation model described below.
Recovering from a strain grants permanent immunity to that strain. Secondary infec-
tions are assumed to lead to DHF with probability ρ. Noise is incorporated into the
transmission parameter, βptq, using external parameter noise (Keeling and Rohani,
2008) and the model is simulated using the Euler-Maruyama algorithm (Kloeden and
Platen, 1992). The stochastic differential equations governing this system are given
by:
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9S0 “ µN ´ βptqItotptqS0ptq
N
´ µS0ptq
9I1 “ βptqItotptqS0ptq
N
´ pν ` µqI1ptq
9S1 “ νI1ptq ´ 3
4
βptqItotptqS1ptq
N
´ µS1ptq
9I2 “ 3
4
βptqItotptqS1ptq
N
´ pν ` µqI2ptq
9S2 “ νI2ptq ´ 2
4
βptqItotptqS2ptq
N
´ µS2ptq
9I3 “ 2
4
βptqItotptqS2ptq
N
´ pν ` µqI3ptq
9S3 “ νI3ptq ´ 1
4
βptqItotptqS3ptq
N
´ µS3ptq
9I4 “ 1
4
βptqItotptqS3ptq
N
´ pν ` µqI4ptq
9S4 “ νI4ptq ´ µS4ptq
9C2 “ νI2ptq
(3.1)
where:
Itotptq “ I1ptq ` I2ptq ` I3ptq ` I4ptq `m
βptq “ βmp1` sinp2˚pipt`φq365 qqp1` ξq
ξ „ Np0, ψ?
dt
q
The observation model assumes that the number of cases of DHF during month
t, denoted Yt, is binomially distributed where the number of trials is equal to the
number of secondary cases of dengue that occurred over the month, Ct2, with proba-
bility of DHF manifestation ρ:
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Yt „ BinomialpCt2, ρq (3.2)
Because observations are made at monthly intervals, the epidemiological model above
is integrated using Euler-Maruyama for a one month time interval between observa-
tions.
3.2.2 Parameter inference
The model described above was used to simulated 23 years of monthly DHF incidence
using parameter values in Table 3.1. Figure 3.2 shows this time series along with
monthly DHF reports in Bangkok from 1981-2005. Both time series exhibit similar
magnitudes and mixtures of annual and multi-annual periodicity. The parameters
from the model that do not have empirical estimates from the literature are βm,
m,,φ,ψ and ρ. These parameters are inferred from the mock time series using particle
Markov Chain Monte Carlo (pMCMC). This is a Bayesian approach which replaces
the exact evaluation of the likelihood function in the standard MCMC algorithm
with a particle filter estimate (Andrieu and Doucet, 2010). This approach allows
one to use MCMC for parameter inference on non-linear, non-Gaussian state space
models such as the one described above. See supplemental section in this chapter
for a mathematical description of the pMCMC algorithm and some techniques for
increasing the speed of the algorithm. Uniform distributions were used for all priors.
In this analysis, initial conditions are treated as nuisance parameters and integrated
out of the particle-filter likelihood estimates (details are given in the particle filter
description in the supplemental section). Four independent chains were run. Each
chain was seeded with a different starting parameter vector which was perturbed
from the true value used to simulate the data.
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3.3 Results
pMCMC along with an importance sampling prior distribution on initial conditions
described in the supplemental section was able to quickly recover the parameters
of interest from the mock simulated data, as well as the initial conditions of the
system. Figure 3.2 shows the estimated posterior distributions of the initial condi-
tions which are sampled during the particle filter likelihood estimate in the particle
MCMC algorithm (See Supplemental Materials section). Each component of the ini-
tial condition vector is well captured by these distributions. The cost of estimating
the initial conditions in this manner comes in the form of increased computation
(more particles are needed for a given level of precision for the likelihood estimates)
and higher variance in the posterior distributions of the parameter values. Figure
3.3 shows the estimated posterior distributions of the parameters where samples are
pooled across chains. The true parameter values used to simulate the mock data
were well captured by each of these distributions.
3.4 Discussion
Using a simple, four-serotype dengue model, I have investigated the plausibility of
recovering the epidemiological parameters of a simple, four serotype dengue model
from a mock time series of monthly DHF which shares many similarities with an em-
pirical time series from Bangkok. Using particle Markov Chain Monte Carlo, I was
able to recover the unknown parameters of the model as well as accurate estimates of
the initial state of the population. While previous work focused on inferring a subset
of unknown parameters while treating many of the epidemiological parameters as
known (Shrestha et al., 2011), this work points towards the plausibility of fitting all
unknown parameters for dengue models to relatively short, highly aggregated time
series. The mock time series used here shares many of the features observed in the
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empirical time series from Bangkok, however, this model will need to be modified if
it is to be used to fit this time series from Bangkok. Perhaps the most important
modification to incorporate will be relaxing the assumption that R0 remains constant
over the course of the time series. As with all simulation based inference techniques,
one of the main hurdles to comparing model variations and exploring parameter
space is computational cost. Even with programming the particle filter in a low-level
language and parallelizing it on multiple processors, these analyses still took over
a month to run. Computational costs ruled out exploring many modifications to
this model that may have allowed the empirical data to be fit. These modifications
include increasing the number of compartments to account for temporary-immunity
following infection and including demographic noise which is computationally very
expensive. This project explored several techniques for taking advantage of multiple
processor computing systems, highly optimized compilers and efficient linear algebra
libraries. The speed-up resulting from these techniques will continue to improve as
new technologies come onto the market. Graphics processing units, along with as-
sociated numerical libraries have the potential to drastically speed up this type of
computation. The many integrated core architecture being developed by Intel could
soon make computing systems with tens or hundreds of cores affordable even for
local desktop computers. All of these technologies may make the type of analysis
done here possible for a much wider range of models very soon. This phenomena
of computational techniques becoming available and needing to wait for computing
capabilities to catch up happens quite often in scientific computing. Examples of
this include numerical integration, Gibbs sampling and Bayesian statistics in gen-
eral. This project has demonstrated the potential for all unknown parameters in a
dengue model to be inferred from even a modest amount of data and outlines several
techniques for speeding up simulation inference techniques. It remains to be seen
whether improved computing resources and advances in parallel computing tech-
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niques will allow for the exploration of models that do a good job of fitting empirical
data and rigorous comparison amongst these models.
3.5 Supplementary Materials
Particle Markov Chain Monte Carlo
Particle Markov Chain Monte Carlo (pMCMC) is an extension of Markov Chain
Monte Carlo which uses a particle filter to estimate the likelihood value (Andrieu
and Doucet, 2010). Let y denote the vector of observation values, θi denote i
th state
of the chain and ICi denote the i
th sample of the initial conditions vector. The prior
distribution on the parameter vector is denoted by pip¨q The pMCMC algorithm pro-
ceeds as follows:
1. Initialize the starting parameter vector θ0. Run a particle filter to obtain
an estimate of the likelihood of θ0, Pˆ py|θ0q and a sample from the posterior
distribution of initial conditions, IC0.
2. for iteration i ě 1
(a) sample θ˚ „ qp¨|θi-1q.
(b) run a particle filter to obtain an estimate of the likelihood of θ˚, Pˆ py|θ˚q
and a sample from the estimated posterior distribution of initial conditions
conditioned on θ˚, IC˚.
(c) With probability minp pipθ˚qPˆ py|θ˚qqpθi-1|θ˚q
pipθi-1qPˆ py|θi-1qqpθ˚|θi-1qq , 1q set θi “ θ˚ and ICi “ IC˚.
Otherwise, set θi “ θi-1 and ICi “ ICi-1.
3. Take tθiu to be a sample from P pθ|yq and tICiu to be a sample from P pIC|yq.
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A single component Metropolis-Hastings algorithm (Gilks et al., 1996) was used
where at each iteration, a parameter was chosen at random to be perturbed using
Gaussian noise. R0 and ρ were blocked into a single component because of their
high negative correlation. This block was sampled according to a bi-variate normal
distribution with negative covariance, which lead to significantly better mixing of
these two parameters.
Particle Filtering Algorithm
A particle filter is a statistical tool for inferring distributions of unknown values in
a state-space model. Here it is used to estimate the posterior density value of a
parameter set, P pθ|yq and also to sample from the posterior distribution of initial
conditions conditioned on the parameter vector and the data, y. Following (Doucet
et al., 2001) the algorithm proceeds as follows:
1. Initialization, t=0
• For i “ 1, ..., N , sample x˜piq0 „ pipx0q and set t “ 1
2. Importance sampling step
• For i “ 1, ..., N, sample x˜piqt „ ppxt|xpiqt´1q and set x˜piq0:t “ pxpiq0:t´1, x˜piqt q
• For i “ 1, ...N , evaluate the importance weights
w˜
piq
t “ gpyt|x˜piqt q Where gp¨|¨q is the density function from the observation
model.
• Let W˜ piqt “ w˜
piq
t
Nř
j“1
w˜
pjq
t
denote the normalized importance weights.
3. Selection step
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• Resample with replacement N particles pxpiq0:t; i “ 1...Nq from the set
px˜piq0:t; i “ 1, ..., Nq according to the normalized importance weights.
• set t=t+1 and go to step 2
An estimate of the likelihood of θ given y is given by:
pˆθ “śTt“0 pˆθpytq
where
pˆθpytq “ 1N
Nř
k“1
w
pkq
t
and a sample from the distribution of initial conditions given y can be obtained by
drawing an index i from discrete distribution tW˜ pjqT u and take xpiq0 as a sample from
this distribution (Doucet et al., 2001). For the prior distribution on initial states,
pip¨q, a 1,000 year trajectory was simulated and N points were then sampled from the
1,000 states from this simulation that had the correct phase, φ. These N samples
are then re-sampled according to gpy0|x0q.
3.5.1 Techniques for reducing runtime
The pMCMC method is very computationally expensive. In this section, I illustrate
a number of techniques that were used in this project to speed up the runtime. About
50% of the runtime was spent generating the Gaussian random variables used in the
simulation of the stochastic differential equations (equations 3.1). The Intel Math
Kernel Library’s Vector Statistical has a very efficient function for generating large
numbers of Gaussian random variables. Using this function resulted in the generation
of Gaussian random variables taking up a non-significant amount of runtime. The
library also has similar functions for evaluating trigonometric functions which are
commonly used to incorporate seasonality into models and the exponential function
which is frequently used for evaluating the likelihood function of the observation
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model.
Another way to significantly speed up a particle filter is to simultaneously step all
particles using matrix algebra. If we let the N denote the number of particles and n
denote the dimension of the process model, then instead of individually stepping N
particles at each step of the filter, the system can be viewed as an N by n matrix, say
M . Now, for instance, when calculating the force of infection for our model, instead
of needing to nN multiplications to calculate the number of deaths in our model, M
can be copied into a buffer matrix and scaled by µ which saves a significant amount
of time because scaling a matrix is faster than individually multiplying each element.
The same thing can be done when calculating the number of recoveries in the model.
The calculation of βptq can now be significantly sped up by generating a vector of
Np1, φ?
dt
q normal random variables using the function described above. This is then
scaled by βmp1` sinp2˚pipt`φq365 qq which now only needs to be calculated once instead
of N times. For this model, this process of stepping the particles simultaneously led
to a 30-40 percent decrease in run time.
The last modification that was used to speed up the particle filter was parallelizing
the stepping process described above. If we let N denote the number of processors
available, at each step of the particle filter,
X
N
N
\
particles can be farmed out to each
processor with one of the processors getting the remaining N mod N particles. This
can lead to a decrease in run-time that’s linear in N depending on how large the
communication costs between processors are relative to the cost of stepping a particle.
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Table 3.1: Parameter values used to simulate mock data
Variable Name Description Value
N Population Size 5 million
µ birth/death rate 1/50 year´1
ν recovery rate 1/5 day´1 (Chan and Johansson, 2012)
βm Transmission rate 1 days
´1
m Import rate 2
 Magnitude of seasonal forcing 0.1
φ Phase 0.5
ψ Magnitude of environmental noise 0.08
ρ P(DHF | Secondary infection) 0.0338 (Sangkawibha et al., 1984)
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Figure 3.1: Mock data used for parameter inference. (A) Reported monthly
DHF from Bangkok over the period 1981-2005. (B) Mock data simulated using
(equation 3.1) and parameters values from Table 3.1.
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Figure 3.2: Posterior distributions of initial conditions Estimated posterior
distributions for S0,S1,S2,S3,S4,I1,I2,I3,I4 respectively. These samples were obtained
using composition sampling to integrate over parameter space.
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Figure 3.3: Parameter posterior distribution estimates The above plots
show the pMCMC posterior density estimates for Ro, , ψ, m, ρ and φ respectively.
Red lines show the true parameter value used to generate the mock data.
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4Conclusions
The focus of this thesis was to illustrate how mathematical modeling can be used to
explore what kinds of models can be fit and implemented for a given data set and
what types of data will be useful to collect in the future. Each chapter addressed
one of these problems in the context of a currently important question in the control
and understanding of infectious diseases in developing countries. The first chapter
addressed a problem that is currently of great interest to the World Health Organi-
zation, which is currently exploring different ways of implementing MMR ( combined
measles, mumps and rubella) vaccination campaigns in the developing world. Each
of these diseases has highest severity in a different age range. The youngest individu-
als are affected the most by measles. Adolescent boys can develop fertility problems
if they become infected with mumps and a rubella infection can be devastating to
a child and mother if she become infected during pregnancy. This makes a vacci-
nation campaign a complicated endeavor because it is more economical to combine
the vaccines but it is not clear that each of these disease should be included in a
campaign if high coverage levels cannot be attained quickly. It has already been seen
in Europe that if high coverage levels are not attained for a disease such as rubella
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or mumps, the country may be better off waiting to begin a vaccination campaign
until higher coverage levels can be attained (Panagiotopoulos et al., 1999). This first
chapter used a simple economic model to illustrate that there may be a threshold
vaccination value for diseases such as rubella or mumps which must be surpassed
in order to see the positive effects of a vaccination policy outweigh it’s negative ef-
fects. This threshold was shown to be lower when the population has a lower level of
age-assortative mixing. This is promising because there is evidence that developing
countries have a lower level of age-assortative mixing and may therefore not need as
high a vaccination level to avoid adverse vaccine effects that have been seen in a low
coverage vaccination campaign in Greece (Panagiotopoulos et al., 1999). Vietnam is
the only country for which this mixing data has been collected (Horby et al., 2011).
This study suggests that this type of data collection should be done in more devel-
oping countries because it can be useful in developing vaccination strategies.
The second project took a more complicated disease, dengue, and explored the
plausibility of model fitting using a modest data set similar to what would be seen in
many developing countries. This results of this project suggest that even relatively
short, low resolution data sets may contain enough signal to fit the parameters of a
dengue model that are not directly measurable. This is a currently relative problem
because modeling cannot be used to inform policy until the model parameters have
been inferred. This project suggests that there is still a significant amount of work to
be done in the area of simulation based inference if it is to be used to inform dengue
control policy. As parallel computing systems become more affordable, it will become
possible to explore a larger array of models and search for the best model for a given
problem.
Each of these projects shows promising results for the diseases that they ad-
dress and suggest work that still remains to be done. The first project shows that
rubella and mumps vaccine coverage levels may not need to be as high as previously
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thought to see positive net effects. The work that remains to be done is to estimate
age-specific mixing information for more developing countries. The second project
suggests that policy makers may not need as long or detailed a data set as previously
believed in order to conduct model inference. The work that remains to be done for
this project is to improve simulation based-inference techniques so that they are less
computationally expensive and to improve the affordability of large-scale parallel
computing systems.
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